Joseph Mossel, Ibex Medical Analytics’ CEO There’s no doubt that cancer screening, early detection, and swift intervention are invaluable for improving patients’ health outcomes. In
Gilead and partner Arcus Biosciences’ anti-TIGIT-based regimen has shown early signs of efficacy in a small group of gastroesophageal cancer patients in a mid-stage trial,
USC Norris Cancer Hospital was named a Top Teaching Hospital by The Leapfrog Group, a leading national patient safety watchdog organization, for the fourth consecutive